Acumen Pharmaceuticals annual revenue
2022
2023
2024
2025
Acumen Pharmaceuticals Revenue Growth & History (ABOS)
Acumen Pharmaceuticals reported $0 in revenue for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
Acumen Pharmaceuticals quarterly revenue
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
Acumen Pharmaceuticals revenue growth trends
Acumen Pharmaceuticals's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Acumen Pharmaceuticals source filings ↗Community posts
Acumen’s cash falls as November Alzheimer’s trial results approach
Acumen ($ABOS) reported $78.6 million of cash, equivalents and marketable securities at the end of its third quarter of 2026, down from $110.2 million three months earlier. Management expects those resources to fund current clinical and ope ...
